3Chopt Investment Partners LLC acquired a new position in shares of Kimberly-Clark Co. (NYSE:KMB - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 6,367 shares of the company's stock, valued at approximately $914,000.
Several other institutional investors and hedge funds have also modified their holdings of KMB. Vanguard Group Inc. lifted its position in shares of Kimberly-Clark by 15.1% during the 4th quarter. Vanguard Group Inc. now owns 35,142,545 shares of the company's stock worth $4,605,079,000 after buying an additional 4,603,787 shares during the last quarter. Norges Bank bought a new stake in shares of Kimberly-Clark during the 4th quarter worth $582,592,000. GAMMA Investing LLC lifted its position in shares of Kimberly-Clark by 10,975.8% during the 1st quarter. GAMMA Investing LLC now owns 1,902,050 shares of the company's stock worth $270,510,000 after buying an additional 1,884,877 shares during the last quarter. First Trust Advisors LP lifted its position in shares of Kimberly-Clark by 163.1% during the 4th quarter. First Trust Advisors LP now owns 2,142,749 shares of the company's stock worth $280,786,000 after buying an additional 1,328,341 shares during the last quarter. Finally, Trinity Financial Advisors LLC bought a new stake in shares of Kimberly-Clark during the 1st quarter worth $181,762,000. 76.29% of the stock is currently owned by institutional investors.
Kimberly-Clark Trading Up 0.8%
Shares of KMB stock traded up $1.05 on Friday, hitting $127.89. The company had a trading volume of 1,935,073 shares, compared to its average volume of 2,198,567. The firm has a market cap of $42.44 billion, a P/E ratio of 16.94, a P/E/G ratio of 4.46 and a beta of 0.38. The stock's 50-day moving average is $134.63 and its two-hundred day moving average is $134.73. The company has a debt-to-equity ratio of 7.05, a quick ratio of 0.54 and a current ratio of 0.80. Kimberly-Clark Co. has a twelve month low of $124.10 and a twelve month high of $150.45.
Kimberly-Clark (NYSE:KMB - Get Free Report) last released its earnings results on Tuesday, April 22nd. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.89 by $0.04. Kimberly-Clark had a return on equity of 201.43% and a net margin of 12.69%. The business had revenue of $4.84 billion during the quarter, compared to analysts' expectations of $4.90 billion. During the same quarter last year, the firm posted $2.01 earnings per share. On average, equities research analysts anticipate that Kimberly-Clark Co. will post 7.5 earnings per share for the current fiscal year.
Kimberly-Clark Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 2nd. Investors of record on Friday, June 6th will be paid a dividend of $1.26 per share. The ex-dividend date is Friday, June 6th. This represents a $5.04 annualized dividend and a yield of 3.94%. Kimberly-Clark's dividend payout ratio is currently 68.66%.
Insider Buying and Selling
In other Kimberly-Clark news, insider Katy Chen sold 740 shares of the firm's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $129.70, for a total value of $95,978.00. Following the completion of the sale, the insider now owns 3,997 shares of the company's stock, valued at approximately $518,410.90. This trade represents a 15.62% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.64% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Several brokerages recently weighed in on KMB. Piper Sandler dropped their price objective on Kimberly-Clark from $158.00 to $156.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Barclays dropped their target price on Kimberly-Clark from $139.00 to $135.00 and set an "equal weight" rating for the company in a research report on Thursday, April 24th. Evercore ISI dropped their target price on Kimberly-Clark from $168.00 to $155.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. JPMorgan Chase & Co. increased their target price on Kimberly-Clark from $124.00 to $131.00 and gave the company an "underweight" rating in a research report on Friday, April 11th. Finally, UBS Group increased their target price on Kimberly-Clark from $134.00 to $146.00 and gave the company a "neutral" rating in a research report on Thursday, April 17th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, Kimberly-Clark has a consensus rating of "Hold" and an average target price of $143.50.
View Our Latest Report on KMB
Kimberly-Clark Company Profile
(
Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Featured Articles

Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report